Fig. 2.

Cytotoxic effects of KP-SeNPs against cancer cells and normal cells. A The cytotoxic effects of KP-SeNPs (100, 150, 200 µg/mL) and KP-RE (100, 150, 200 µg/mL) on the AGS cells. Cisplatin (50 µM) was used as the positive control. B The cytotoxic effects of KP-SeNPs (100, 150, 200 µg/mL), KP-RE (100, 150, 200 µg/mL) and cisplatin (50 µM) against control HaCaT cells. C, D Microscopic images and wound-healing assay of AGS cells treated with KP-SeNPs (150, 200 µg/mL), KP-RE (150, 200 µg/mL), and Cisplatin (50 µM). *p < 0.05, ** p < 0.01, ***p < 0.001 compared with control